Aspiriant, LLC has filed its 13F form on October 17, 2024 for Q3 2024 where it was disclosed a total value porftolio of $2.61 Billion distributed in 292 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ishares Msci Global Min Vol Fa with a value of $276M, Ishares Core S&P U.S. Value Et with a value of $274M, Vanguard Mun Bd Fds Tax Exempt with a value of $266M, Ishares Core S&P 500 ETF with a value of $254M, and Vanguard Dividend Appreciation with a value of $176M.

Examining the 13F form we can see an increase of $162M in the current position value, from $2.45B to 2.61B.

Below you can find more details about Aspiriant, LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.61 Billion
ETFs: $2.29 Billion
Technology: $117 Million
Financial Services: $65 Million
Communication Services: $32.1 Million
Healthcare: $21.1 Million
Consumer Cyclical: $18.6 Million
Industrials: $16.8 Million
Consumer Defensive: $14.1 Million
Other: $12.3 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 292
  • Current Value $2.61 Billion
  • Prior Value $2.45 Billion
  • Filing
  • Period Q3 2024
  • Filing Date October 17, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 28 stocks
  • Additional Purchases 96 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 119 stocks
Track This Portfolio

Track Aspiriant, LLC Portfolio

Follow Aspiriant, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.